Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Fractional light-based technology licensing

This article was originally published in The Gray Sheet

Executive Summary

Palomar Medical Technologies and Reliant Technologies form Fractional Technology Open Patent Program to out-license intellectual property and encourage further development of fractional light-based products by others in the industry, the firms announce Nov. 11. The initiative includes six fractional patent families owned or controlled by Palomar, Reliant and Massachusetts General Hospital. Palomar and Reliant note that they also have entered into certain cross-license agreements. Fractional technology is used in dermatology procedures to deliver laser or high-powered light energy to the skin in a pattern that leaves untreated areas between the treated areas. Reliant's pending merger with aesthetic device maker Thermage is set to close in the fourth quarter (1"The Gray Sheet" July 14, 2008, p. 11)

Latest Headlines
See All
UsernamePublicRestriction

Register

MT026799

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel